India’s generics exports expanding 22% per year

25 Oct 2017

Country accounts for over 20% of global production with $20 billion exports forecast by 2020.

The India Brand Equity foundation (IBEF) and the Pharmaceuticals Export Promotion Council (PHARMEXCIL) provide an update on the country’s generics market as the world’s pharma industry meets for its annual exposition at CPhI Worldview in Frankfurt. Data confirms that the country’s branded generic sector accounts for a massive 98% of the marketplace – reaching a value in excess of US$12 billion – with India remaining the world’s leading exporter.

India’s generics exports expanding 22% per year

PHARMEXCIL confidently forecast that generic exports are now growing at around 22% per year, with India accounting for around 20-22% of the world’s production, covering more than 60,000 brands and 60 therapeutic classes.

Total exports of pharmaceuticals – including APIs, generics and alternative systems of medicine – climbed to $16.84 billion during 2016-17, with 34% and 15% supplied to the US and EU markets respectively.

Shri Ravi Udaya Bhaskar, Director General, Pharmexcil, commented: “A key driver for this growth is India’s extensive product portfolio, which provides the capability to manage and treat any ATC (Anatomical therapy classification) – to the same quality as the innovators – at highly affordable costs.”

According to the analysis India has provided up to 50% of new DMFs and between a quarter and a third of new ANDAs each year for the past decade – in addition to supporting hundreds of ANDAs filed by US and EU companies. The country was also credited with between 30% and 50% of the total CEPS between 2013 and 2017, including being the first to file generic drugs in the EU and the US. Consequently, India now boasts 7 companies amongst the top 20 global generic organisations.

Shri Ravi Udaya Bhaskar, added:“The industry has been working diligently towards enhancing its capabilities and strengths. This includes its more than 950 colleges, which deliver over 90,000 pharmaceutical graduates per year, of which, 30,000 have completed master’s degrees. Moreover, Government’s policies are directed at increasing infrastructure facilities to help enable manufacturing to reach its highest potential – with pharma exports expected to reach $20 billion by 2020.”

Read More

Related news

Innovation awarded at Pharmapack

Innovation awarded at Pharmapack

10 Feb 2020

Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.

Read more 
Digital value-added medicines - a key driver for 2020

Digital value-added medicines - a key driver for 2020

29 Jan 2020

Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead.

Read more 
CPhI and AAPS partner to expand expert scientific content at CPhI North America

CPhI and AAPS partner to expand expert scientific content at CPhI North America

10 Jan 2020

CPhI and the American Association of Pharmaceutical Scientists (AAPS) today announced a partnership to expand the scientific content of activities sponsored by CPhI, including CPhI North America—the only event to bring the entire North American pharmac...

Read more 
Innovation and regulatory harmonisation to drive Indian pharma in 2020

Innovation and regulatory harmonisation to drive Indian pharma in 2020

18 Dec 2019

Experts suggest the continued goal of aligning India to Western regulatory standards will help the country sustain significant increases in exports.

Read more 
Connectivity, customization and sustainability driving packaging and drug delivery in 2020

Connectivity, customization and sustainability driving packaging and drug delivery in 2020

4 Dec 2019

Pharmapack 2020 gathering top specialists and pioneers to exchange their vision on best strategies to tackle key challenges.

Read more 
Worldwide event predicts global pharma trends for 2020

Worldwide event predicts global pharma trends for 2020

27 Nov 2019

Content sessions identify value-added medicines, preventive drugs, early diagnostics and patient experience as some of the trends for the year ahead.

Read more 
India pharma forecast to grow strongly in 2020

India pharma forecast to grow strongly in 2020

22 Nov 2019

The rise in exports growth potential is believed to be in response to concerted reforms by the CDSCO and industry quality improvements in the last few years.

Read more 
Winners of the 16th Pharma Awards

Winners of the 16th Pharma Awards

11 Nov 2019

Companies and individuals from across the whole pharma supply chain recognised for their excellence and commitment.

Read more 
CDMOs to benefit from rising BTDs, orphan drugs and fast track status therapies

CDMOs to benefit from rising BTDs, orphan drugs and fast track status therapies

8 Nov 2019

But personalized medicines will require new logistics and manufacturing systems.

Read more 
Europe predicted to surpass the US in biologic manufacturing capacity by 2023

Europe predicted to surpass the US in biologic manufacturing capacity by 2023

6 Nov 2019

Demand for biological manufacturing is growing faster than capacity growth.

Read more